You can admit to this center with a primary substance use disorder or a primary mental health condition. You'll receive support each step of the way and individualized care catered to your unique situation and diagnosis.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
This provider hasn't verified their profile's information. Are you the owner of this center? Claim your listing to better manage your presence on Recovery.com.
You can admit to this center with a primary substance use disorder or a primary mental health condition. You'll receive support each step of the way and individualized care catered to your unique situation and diagnosis.
Offering intensive care with 24/7 monitoring, residential treatment is typically 30 days and can cover multiple levels of care. Length can range from 14 to 90 days typically.
Our admissions team will work with you to explore the right payment options based on your needs, ensuring you get the best possible treatment.
OhioGuidestone’s Renewal Center in Napoleon, Ohio helps men 18 and older recover from substance use disorders through residential care at Levels 3.5 and 3.1. The center supports clients with serious addiction needs, offering a 90-day structured stay. Medication-assisted treatment and strong transition planning help men succeed in long-term recovery.
The center uses group and individual therapy, dual diagnosis treatment, and skill-building sessions. Clients also receive support through sober peer networks and connections to community resources. These therapies teach coping tools, boost emotional health, and help clients rebuild confidence and routines that support a clean and stable life.
Clients learn job skills, receive transportation help, and build sober support systems. Staff guide them through reintegration into daily life with a warm handoff to outside services. The average stay gives time to grow and heal, and the small 24-person size allows for focused attention in a calm, supportive setting.
You can admit to this center with a primary substance use disorder or a primary mental health condition. You'll receive support each step of the way and individualized care catered to your unique situation and diagnosis.
Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT
Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.
Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.
Suboxone®, Subutex®, Sublocade®, Zubsolv®
Buprenorphine is a partial opioid agonist used to treat opioid use disorder. It activates opioid receptors to reduce cravings and withdrawal but has a ceiling effect, meaning it produces less euphoria and respiratory depression than full opioids.
Buprenorphine binds tightly to opioid receptors, blocking other opioids from attaching and reducing the risk of misuse. It's often combined with naloxone (as in Suboxone®) to discourage injection misuse and is available in daily or monthly forms.